Management of elderly patients with acute promyelocytic leukemia: progress and problems.

Item

http://www.wikidata.org/entity/Q38108471

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Management of elderly patients with acute promyelocytic leukemia: progress and problems.

@en

type

Item

label

Management of elderly patients with acute promyelocytic leukemia: progress and problems.

@en

prefLabel

Management of elderly patients with acute promyelocytic leukemia: progress and problems.

@en

P1476

Management of elderly patients with acute promyelocytic leukemia: progress and problems.

@en

P2093

Eva Lengfelder

http://www.w3.org/2001/XMLSchema#string

Florian Nolte

http://www.w3.org/2001/XMLSchema#string

Wolf-Karsten Hofmann

http://www.w3.org/2001/XMLSchema#string

P2860

Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML

A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group

Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups

United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia

The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome.

Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience.

All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.

Treatment advances have not improved the early death rate in acute promyelocytic leukemia.

Acute promyelocytic leukemia: a population-based study on incidence and survival in the United States, 1975-2008.

P304

1181-1188

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S00277-013-1788-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236929133

http://www.w3.org/2001/XMLSchema#string

P698

23694997

http://www.w3.org/2001/XMLSchema#string

P921

acute promyelocytic leukemia

P932

3734597

http://www.w3.org/2001/XMLSchema#string